Proqr Therapeutics NV has received clinical trial application (CTA) authorization under the EMA’s new centralized review process for a phase I study of AX-0810, which is being developed for the ...
Several pension funds in Europe are reviewing long-standing exclusion policies on weapons manufacturers, as they work to update their portfolios to match the political moment. PFA Pension, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results